Vioxx Withdrawal Subject of SEC, Justice Department Probes

The Justice Department has issued a subpoena to Merck & Co. for the way it researched, marketed and sold Vioxx, the drugmaker said in a regulatory filing.

Merck, which pulled Vioxx from the shelves in September, also said it faces an informal investigation by the Securities and Exchange Commission, the Wall Street Journal reported.

The company took Vioxx off the market after it conducted a study

Click Here

that showed a doubled risk of heart attack or stroke in patients who took the once-a-day painkiller for longer than 18 months.

Although Merck has steadfastly defended its actions, it said it will cooperate with the SEC and the Justice Department. Justice's inquiry is connected to a federal health-care investigation under criminal statutes, the company said in its filing.

The company said it "cannot predict the outcome of these inquiries, however, it is possible that highly unfavorable outcomes, including a potential civil disposition from the SEC and/or potential civil or criminal dispositions from the Justice Department, could have a material adverse effect" on its finances, liquidity and results.

Some medical experts are saying that Vioxx should have been withdrawn years ago. According to the British medical journal Lancet, which published an analysis of public clinical-trial data, clinical evidence of harmful side effects would have justified the withdrawal. A Lancet editorial characterized the approval of Vioxx by regulators and its subsequent sale as "public health catastrophes."

Merck said last week that it “acted responsibly and appropriately as it developed and marketed Vioxx, and made decisions based on all available data at the time.” The company said the Lancet study was not based on new data and that the company's own analyses were more comprehensive.

Merck's stock prices have not recovered from the Vioxx controversy, as shares sold Monday at $26.57, compared with a high of about $50 set in February.

You may like these other stories...

By Teresa Ambord, Correspondent You'd think a man who masterminded the biggest Ponzi scheme in history would have ice water in his veins. The name Bernard Madoff has become synonymous with investment scams after his...
By Ken Berry In a new case decided by the US Supreme Court, the remnants of a tax shelter partially constructed by wily Texas billionaire Billy Joe McCombs - known informally as "Red" - collapsed like a house...
By Teresa Ambord, Correspondent The IRS has suffered numerous hits lately, though they'd be hard pressed to find much sympathy from the public. Recent months have seen fumble after fumble in the news, and here's...

Upcoming CPE Webinars

Apr 22
Is everyone at your organization meeting your client service expectations? Let client service expert, Kristen Rampe, CPA help you establish a reputation of top-tier service in every facet of your firm during this one hour webinar.
Apr 24
In this session Excel expert David Ringstrom, CPA introduces you to a powerful but underutilized macro feature in Excel.
Apr 25
This material focuses on the principles of accounting for non-profit organizations' revenues. It will include discussions of revenue recognition for cash and non-cash contributions as well as other revenues commonly received by non-profit organizations.
Apr 30
During the second session of a four-part series on Individual Leadership, the focus will be on time management- a critical success factor for effective leadership. Each person has 24 hours of time to spend each day; the key is making wise investments and knowing what investments yield the greatest return.